Lower than three weeks after saying an formidable $110 million growth into Virginia, the place adult-use marijuana gross sales are anticipated to start someday subsequent yr, Curaleaf Holdings’ buy of competitor The Cannabist Firm Holdings’ belongings within the state is off.
The rationale why New York-based Curaleaf received’t buy a vertically built-in medical hashish allow in any case? A competing provide for a complete of $160 million materialized, Curaleaf stated in a press launch Friday.
The Curaleaf deal, finalized Dec. 1, was set to shut within the first quarter of 2026 and included Cannabist’s 5 present shops within the Richmond, Virginia, space and an 83,000-square-foot cultivation operation, with the precise to open a sixth retailer.
However on Thursday, the identical day President Donald Trump issued an government order downgrading hashish’ standing below federal legislation, Massachusetts-based Cannabist stated it is going to promote its Virginia allow to an affiliate of Millstreet Credit score Fund for $130 million, “topic to adjustment.”
Millstreet is a Boston-based hedge fund, based on Securities and Trade Fee filings.
Curaleaf’s provide was for $80 million in money up entrance, $20 million to be paid inside 30 days and a $10 million promissory observe at 6% curiosity.
It wasn’t instantly clear whether or not the extra beneficiant deal was straight associated to the prospects of hashish turning into a Schedule 3 drug.
Will increase worth for marijuana MSO after Trump rescheduling
In keeping with a Cannabist press launch, the deal is for $117.5 million in money “payable … upon closing.” In keeping with Curaleaf, that deal additionally consists of “the idea of a $30 million lease legal responsibility.”
Proceeds from the sale will fulfill debt coming due on the finish of 2028, based on The Cannabist Co.
Curaleaf remains to be due a $3.3 million “break-up price” from Cannabist on account of the latter firm accepting the extra profitable provide, based on a press launch.
Virginia adult-use marijuana gross sales potential
Virginia’s medical hashish market is severely restricted by legislation to solely 5 vertically built-in permits, every of which is restricted to a particular geographic area.
Regardless of that, the state reported practically $30 million in gross sales in July and August, the primary two months of state-mandated track-and-trace monitoring.
Grownup-use hashish gross sales may attain $780 million within the first full yr of gross sales and exceed $1.09 billion by the second yr, based on the MjBiz Factbook.
In keeping with a 2020 research commissioned by state lawmakers, Virginia may assist between:
- 100 and 800 cultivation permits
- 30 and 150 processing or distribution licenses
- 200 and 600 retail licenses
The opposite 4 present medical marijuana permits are held by:
- Miami-based MSO Ayr Wellness, which has but to open a dispensary and just lately offered off belongings, together with the Virginia allow, to collectors
- Boca Raton, Florida-based Jushi
- Chicago-based Inexperienced Thumb Industries
- Chicago-based Verano Holdings Corp.
Subscribe to the MJBiz Factbook
Unique business knowledge and evaluation that will help you make knowledgeable enterprise choices and keep away from expensive missteps. All of the information, not one of the hype.
What you’re going to get:
- Month-to-month and quarterly updates, with new knowledge & insights
- Monetary forecasts + capital funding traits
- State-by-state information to rules, taxes & market alternatives
- Annual survey of hashish companies
- Shopper insights
- And extra!
In an adult-use state of affairs – thought-about to be an inevitability, with Democratic Gov.-elect Virginia Spanberger pledging to lastly launch adult-use gross sales within the South – it stays to be seen whether or not present medical operators will get first dibs as in Maryland, or whether or not regulators will give desire to small enterprise, a la New York state.
